- Supported exchanges /
- SHE /
- 301207.SHE
Hualan Biological Bacterin Inc. (301207 SHE) stock market data APIs
Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China.
Hualan Biological Bacterin Inc. Financial Data Overview
| 20.78 | |
| 18.99 | |
| - | |
| 21 | |
| 18.51 | |
| 15.42-34.8553 | |
| 12 489 M | |
| 16.1085 | |
| 601 M | |
| 2 296 M | |
| -0.0222 | |
| 0.0289 | |
| 0.802 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Hualan Biological Bacterin Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 296 M
- EBITDA 914 M
- Earnings Per Share 1.29
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Hualan Biological Bacterin Inc. Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get Hualan Biological Bacterin Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
